| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SECT-B.ST - | HOLD | 0 @ SEK 21.2054 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 21.2054. The average price that SECT-B.ST shares were previous bought at was SEK 28.5764. The current market price is -25.8% lower than average price they were purchased at. The value of the holding in SECT-B.ST has increased by SEK 19,228 (USD $2,110) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 136 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 136. The average price that IPN.PA shares were previous bought at was EUR 104.662. The current market price is 29.9% higher than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 49,530 (USD $57,816) compared to the previous valuation of Ipsen SA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 598.312 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 598.312. The average price that LONN.SW shares were previous bought at was CHF 604.613. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 46,410 (USD $58,275) compared to the previous valuation of |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 128.4 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 128.4. The average price that MRK.DE shares were previous bought at was EUR 116.341. The current market price is 10.4% higher than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 235,584 (USD $274,996) compared to the previous valuation of Merck KGaA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 124.038 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 124.038. The average price that NOVN.SW shares were previous bought at was CHF 102.38. The current market price is 21.2% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 797,062 (USD $1,000,844) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 53.114 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 53.114. The average price that NOVO-B.CO shares were previous bought at was DKK 62.0089. The current market price is -14.3% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 4,173,695 (USD $652,197) compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| NSIS-B.CO - | HOLD | 0 @ DKK 55.042 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 55.042. The average price that NSIS-B.CO shares were previous bought at was DKK 60.4828. The current market price is -9.0% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has increased by DKK 69,128 (USD $10,802) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 69.4 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 69.4. The average price that ORNBV.HE shares were previous bought at was EUR 60.3732. The current market price is 15.0% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 34,467 (USD $40,233) compared to the previous valuation of Orion Oyj however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 25.35 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 25.35. The average price that PHIA.AS shares were previous bought at was EUR 21.2058. The current market price is 19.5% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 218,375 (USD $254,908) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 46.7 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 46.7. The average price that REC.MI shares were previous bought at was EUR 53.1347. The current market price is -12.1% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 13,106 (USD $15,299) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 374.915 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 374.915. The average price that ROG.SW shares were previous bought at was CHF 286.083. The current market price is 31.1% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 1,174,108 (USD $1,474,288) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 79.76 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 79.76. The average price that SAN.PA shares were previous bought at was EUR 88.5053. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 655,353 (USD $764,992) compared to the previous valuation of Sanofi SA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 67.0299 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 67.0299. The average price that SDZ.SW shares were previous bought at was CHF 45.334. The current market price is 47.9% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 56,905 (USD $71,454) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.34331 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.34331. The average price that HLN.L shares were previous bought at was GBP 4.55196. The current market price is -4.6% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 57,251 (USD $76,827) compared to the previous valuation of Haleon PLC however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| SFZN.SW - | HOLD | 0 @ CHF 93.8635 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 93.8635. The average price that SFZN.SW shares were previous bought at was CHF 104.924. The current market price is -10.5% lower than average price they were purchased at. The value of the holding in SFZN.SW has increased by CHF 3,918 (USD $4,920) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 44.11 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 44.11. The average price that SHL.DE shares were previous bought at was EUR 47.75. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 66,300 (USD $77,392) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.1924 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.1924. The average price that SN.L shares were previous bought at was GBP 12.8575. The current market price is 10.4% higher than average price they were purchased at. The value of the holding in SN.L has increased by GBP 84,785 (USD $113,776) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 31.4587 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 31.4587. The average price that SOBI.ST shares were previous bought at was SEK 26.7916. The current market price is 17.4% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 57,040 (USD $6,258) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 239.67 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 239.67. The average price that SOON.SW shares were previous bought at was CHF 268.015. The current market price is -10.6% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 33,717 (USD $42,337) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 261.4 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 261.4. The average price that SRT3.DE shares were previous bought at was EUR 217.994. The current market price is 19.9% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 94,447 (USD $110,248) compared to the previous valuation of Sartorius AG however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 105.588 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 105.588. The average price that STMN.SW shares were previous bought at was CHF 112.761. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 50,043 (USD $62,837) compared to the previous valuation of |
| TECN.SW - | HOLD | 0 @ CHF 153.996 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 153.996. The average price that TECN.SW shares were previous bought at was CHF 175.966. The current market price is -12.5% lower than average price they were purchased at. The value of the holding in TECN.SW has fallen by CHF 2,965 (USD $3,723) compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 222 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 222. The average price that TUB.BR shares were previous bought at was EUR 134.464. The current market price is 65.1% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 35,968 (USD $41,985) compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 258.9 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 258.9. The average price that UCB.BR shares were previous bought at was EUR 167.894. The current market price is 54.2% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 314,946 (USD $367,636) compared to the previous valuation of UCB SA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 58.0679 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 58.0679. The average price that ZEAL.CO shares were previous bought at was DKK 59.1439. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in ZEAL.CO has increased by DKK 87,479 (USD $13,670) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 31.3569 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 31.3569. The average price that DEMANT.CO shares were previous bought at was DKK 35.1227. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 26,619 (USD $4,160) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 69.7025 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 69.7025. The average price that ALC.SW shares were previous bought at was CHF 77.0204. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 57,529 (USD $72,237) compared to the previous valuation of |
| ALK-B.CO - | HOLD | 0 @ DKK 29.5628 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 29.5628. The average price that ALK-B.CO shares were previous bought at was DKK 24.063. The current market price is 22.9% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 5,860 (USD $916) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 11.8559 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 11.8559. The average price that AMBU-B.CO shares were previous bought at was DKK 13.7187. The current market price is -13.6% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has increased by DKK 22,259 (USD $3,478) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 13.77 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 13.77. The average price that AMP.MI shares were previous bought at was EUR 19.8189. The current market price is -30.5% lower than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Amplifon SpA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 699 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 699. The average price that ARGX.BR shares were previous bought at was EUR 525.504. The current market price is 33.0% higher than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 78,189 (USD $91,270) compared to the previous valuation of Argenx SE however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 155.766 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 155.766. The average price that AZN.L shares were previous bought at was GBP 127.143. The current market price is 22.5% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 1,784,098 (USD $2,394,152) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| BAVA.CO - | HOLD | 0 @ DKK 26.7779 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 26.7779. The average price that BAVA.CO shares were previous bought at was DKK 23.0839. The current market price is 16.0% higher than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 12,733 (USD $1,990) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 44.165 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 44.165. The average price that BAYN.DE shares were previous bought at was EUR 26.2448. The current market price is 68.3% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 615,676 (USD $718,677) compared to the previous valuation of Bayer AG however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 104.6 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 104.6. The average price that BIM.PA shares were previous bought at was EUR 118.427. The current market price is -11.7% lower than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 4,095 (USD $4,780) compared to the previous valuation of BioMerieux however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| CAMX.ST - | HOLD | 0 @ SEK 65.0984 | SEK 0 | The current share valuation price of CAMX.ST based on adjusted close was SEK 65.0984. The average price that CAMX.ST shares were previous bought at was SEK 56.2613. The current market price is 15.7% higher than average price they were purchased at. The value of the holding in CAMX.ST has increased by SEK 45,202 (USD $4,959) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 74.0409 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 74.0409. The average price that COLO-B.CO shares were previous bought at was DKK 85.2136. The current market price is -13.1% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 50,104 (USD $7,829) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.71787 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.71787. The average price that CTEC.L shares were previous bought at was GBP 3.01533. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in CTEC.L has increased by GBP 72,242 (USD $96,944) compared to the previous valuation of ConvaTec Group PLC however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 104 | EUR 0 | The current share valuation price of ABVX.PA based on adjusted close was EUR 104. The average price that ABVX.PA shares were previous bought at was EUR 100.227. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in ABVX.PA has increased by EUR 36,110 (USD $42,151) compared to the previous valuation of Abivax SA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 209.6 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 209.6. The average price that DIM.PA shares were previous bought at was EUR 199.575. The current market price is 5.0% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 65,464 (USD $76,416) compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 268 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 268. The average price that EL.PA shares were previous bought at was EUR 250.248. The current market price is 7.1% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 26,484 (USD $30,915) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 71.36 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 71.36. The average price that ERF.PA shares were previous bought at was EUR 58.4412. The current market price is 22.1% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 67,201 (USD $78,444) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 37.49 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 37.49. The average price that FME.DE shares were previous bought at was EUR 47.4075. The current market price is -20.9% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 76,448 (USD $89,238) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 48.47 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 48.47. The average price that FRE.DE shares were previous bought at was EUR 42.8728. The current market price is 13.1% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 144,425 (USD $168,587) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 163.803 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 163.803. The average price that GALD.SW shares were previous bought at was CHF 128.821. The current market price is 27.2% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 77,519 (USD $97,338) compared to the previous valuation of |
| GETI-B.ST - | HOLD | 0 @ SEK 19.9308 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 19.9308. The average price that GETI-B.ST shares were previous bought at was SEK 17.466. The current market price is 14.1% higher than average price they were purchased at. The value of the holding in GETI-B.ST has increased by SEK 27,911 (USD $3,062) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 283.578 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 283.578. The average price that GMAB.CO shares were previous bought at was DKK 192.304. The current market price is 47.5% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 110,944 (USD $17,337) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.89 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.89. The average price that GRF.MC shares were previous bought at was EUR 10.445. The current market price is 4.3% higher than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 40,336 (USD $47,084) compared to the previous valuation of Grifols SA however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 20.7286 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 20.7286. The average price that GSK.L shares were previous bought at was GBP 17.2647. The current market price is 20.1% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 375,796 (USD $504,296) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 18.0119 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 18.0119. The average price that HIK.L shares were previous bought at was GBP 23.5355. The current market price is -23.5% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 39,144 (USD $52,529) compared to the previous valuation of however if the holding was sold on 2026-01-22 this would crystalise an overall loss. |